BN

Bart Neyns

Mutual Connections
Loading...
S9-052025-0913346

Send Message

No file chosen
1 Publications
0 Followers
0 Following
0 Questions

👤 About

Skills & Expertise

No skills added yet.

Research Interests

No research interests added yet.

Connect With Me

📚 Publications (1)

Journal: Cancer Investigation • October 2012
Ipilimumab 3 mg/kg was the first agent to improve survival of pretreated advanced melanoma patients. Nonconventional response patterns to ipilimumab have been reported widely, but most of these data w...
Ipilimumab European expanded access program Case reports
dd